Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2023. Start Trial.
Date Value
October 05, 2026 1.943
October 02, 2026 1.982
October 01, 2026 1.989
September 30, 2026 2.120
September 29, 2026 2.073
September 28, 2026 2.057
September 25, 2026 2.105
September 24, 2026 2.136
September 23, 2026 2.268
September 22, 2026 2.432
September 21, 2026 2.302
September 18, 2026 2.302
September 17, 2026 2.266
September 16, 2026 2.250
September 15, 2026 2.286
September 14, 2026 2.406
September 11, 2026 2.397
September 10, 2026 2.568
September 09, 2026 2.604
September 08, 2026 2.761
September 04, 2026 2.763
September 03, 2026 2.763
September 02, 2026 2.729
September 01, 2026 2.765
August 31, 2026 2.781
Date Value
August 28, 2026 2.772
August 27, 2026 2.822
August 26, 2026 2.945
August 25, 2026 2.942
August 24, 2026 2.992
August 21, 2026 2.971
August 20, 2026 2.983
August 19, 2026 3.081
August 18, 2026 2.994
August 17, 2026 2.983
August 14, 2026 2.938
August 13, 2026 2.910
August 12, 2026 2.926
August 11, 2026 2.895
August 10, 2026 2.897
August 07, 2026 2.879
August 06, 2026 2.811
August 05, 2026 2.740
August 04, 2026 2.722
August 03, 2026 2.699
July 31, 2026 2.568
July 30, 2026 2.545
July 29, 2026 2.461
July 28, 2026 2.510
July 27, 2026 2.502

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Novartis AG 6.202
Roche Holding AG --
Addex Therapeutics Ltd. 1.430
Sandoz Group AG --
Galderma Group AG --

Price to Book Value Related Metrics

Price 8.72
Earnings Yield -20.17%
Market Cap 538.30M